You have read all your free articles, to continue reading subscribe to read the rest of this content.
InDex Pharmaceuticals Holding announces that a patent covering 19 compounds from the company's DIMS platform has been granted by the United States Patent and Trademark Office (USPTO). InDex has a discovery stage portfolio of more than 150 DNA-based ImmunoModulatory Sequences (DIMS), several of whAlready a subscriber Login You have read…
The European Patent Office has granted a further European patent to the company, entitled “Antigen and method for production thereof”. The granted European patent follows the approval of the US-member of this patent family already in 2018 under US Patent 10,159,729 B2. “We’re excited aAlready a subscriber Login You have…
Modus Therapeutics has been granted two patents in the US covering its proprietary compound sevuparin. More specifically the two patents have been granted claims for the substance sevuparin per se and a manufacturing method for producing sevuparin (U.S. Patent no. 9,480,701) as well as its use inAlready a subscriber Login…
Spago Nanomedical has received notice from the European Patent Office (EPO) that it intends to grant the company's patent application including a critical component of the SpagoPix candidate drug SN132D. The granted patent will extend protection of SpagoPix in Europe until at least 2038. The secAlready a subscriber Login You…
